Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Erchonia Corporation – Silver Sponsors at the Aesthetic Medicine World Congress in Monaco
  • USA - English


News provided by

Erchonia Corp.

Apr 03, 2017, 09:20 ET

Share this article

Share toX

Share this article

Share toX

Verju Before & After's
Verju Before & After's

We are very excited by the growth that we are achieving across the pond. And we are confident Verju will prove to be ‘THE’ popular choice for those seeking a non-invasive fat loss or cellulite removal solution. -Charlie Shanks, VP of Erchonia Corp.

Post this

Melbourne, FL (PRWEB) April 03, 2017 -- Erchonia, the global leader in low level laser healthcare applications, announces their silver sponsorship of the 2017 AMWC (Aesthetic Medicine World Congress) in Monaco (Venue: Grimaldi Forum, Monte Carlo, Monaco Dates: 06-08th April 2017.). At the forefront once again will be the non-invasive Verju laser, FDA market cleared for the circumferential reduction of the waist, hips & thighs, the appearance of cellulite, and more recently ‘Obesity,’ and the newly FDA market cleared Lunula Laser, for the stimulation of new, clear nail growth. The Verju went on official release in Europe last year and can now be found in clinics around most European countries, as can the ever popular Lunula Laser.                                                                    

The Verju laser is the only device on the market proven effective with a double-blind, multi-site, placebo-controlled study that delivered an average four inch loss after two weeks of treatment.

The Verju protocol consists of six, painless, 30 minute treatments; over two, three, or six weeks depending on the needs of the client. Erchonia’s Verju laser produces a low-level output that has no thermal effect on the body's tissue and, unlike the majority of other devices on the market, its unique technology does not kill or damage fat cells and as per the FDA clearance, provides a ‘non-temporary’ result. The Verju laser instead creates a pore in each cell for the fat to leak out. The fat is then processed naturally through the lymphatic system, leaving the cell intact.

Leading cosmetic doctor, Dr. Miguel Montero from ‘Discover Laser’ in the UK will be presenting his workshop at AMWC titled “The World’s First and Only Green Laser to receive FDA Clearance for Non-Temporary, Non-Invasive Body Contouring/Fat Loss and reduction in the appearance of cellulite” on 7th April in the Van Dongen room from 5.30 pm-6.30 pm.

“Following on from what has been a very successful year since the 2016 AMWC, we are delighted to be back again this year as silver sponsors,” says Simon Ramshaw, Managing Director of UK based Erchonia Lasers Ltd. “We now have representation in a lot of new European markets and we are looking to continue our rapid growth in 2017 and beyond. To make a real change to people’s lives, you have to push the boundaries, and we believe patients will revel in not just the clinically proven aesthetic benefits but the health benefits that our lasers bring. In tandem, this is what makes us stand out from other less effective technologies.”

Here is what our existing clientele say about Verju:

Dr. Juan Mendieta` Plastic Surgeon, Clinica Medicina Estetica Medicos Medicos, Spain
“I chose Verju because I like to give my patients the best. I am happy with the results it gives me and the way the patient changes shape simply relaxing under the laser.”

MD. Dinko Bagatin, specialist in general and plastic surgery clinic Bagatin, Zagreb
"Verju cold laser is the best alternative to surgical methods of body shaping. It provides excellent results, lowers volume in a very short period, and the recovery after treatment is not there. Anyone who is afraid of surgery, I recommend this excellent laser treatment."

Dr. Ivija Rajkovic, Medikol Clinic, Zagreb
“In addition to aesthetic purposes, is the unquestionable importance and usefulness Verju laser has in patients who struggle with obesity of any type. Non-invasive and painless, Verju showed a convincing result in the elimination of body fat, especially in patients who have problems with stubborn fat deposits in the abdominal area. Verju is a necessary therapy in the prevention and treatment of obesity.”

Dr. Jasenka Kalajdžić - Čandrlić, clinic Lege Artis, Osijek
"Until now, numerous patients have undergone Verju treatments. Results of treatment have absolutely justified Verju owning FDA certificates for body shaping, volume reduction and removal of fat in obese patients. The results are truly astounding."

Avelina Kaselic-Kraljevic, MD., Medical Aesthetic Center Jupiter, Rijeka
"Green Verju laser is a top treatment that achieves excellent results, and patients do not feel anything that could cause discomfort. Indeed, usually half an hour after hatching under laser light, result is guaranteed. We are proud that we have in our offer included Verju and thereby increase the number of satisfied customers.”

For more information, please visit http://www.Erchonia.com or http://www.Verju.com.

About Erchonia
Erchonia is the global leader in low level laser healthcare applications. For over two decades, Erchonia has been conducting research & development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, treat the appearance of cellulite, stimulate new clear nail growth for onychomycosis sufferers, veterinary applications and eliminate pain.

Charlie Shanks, Erchonia Corp., (888) 242-0571 cshanks(at)erchonia(dot)com
Julie Davies, Erchonia Europe., +44 1491 821135 jdavies(at)erchoniaeurope(dot)com

Charlie Shanks, Erchonia Corp., http://www.erchonia.com, +1 (888) 242-0571, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.